Why the study?
Does standard cardiac therapy improve left ventricular dysfunction in a patient with late-onset doxorubicin-induced congestive heart failure?
Population
1 adult patient who developed doxorubicin-induced congestive heart failure one year after receiving a…
Design
Case_report
Authors
Loading...
May indicate reversibility with standard therapy in this case; leaves open generalizability and need for prospective trials.
Does standard cardiac therapy improve left ventricular dysfunction in a patient with late-onset doxorubicin-induced congestive heart failure?
This case report demonstrates that late-onset doxorubicin-induced cardiomyopathy can be reversible and responsive to standard cardiac therapy.
M. Cohen (1982) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: